We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App




Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

By LabMedica International staff writers
Posted on 21 Apr 2026

Seegene introduced STAgora, a real-time data analytics platform built on aggregated statistical testing data, at ESCMID Global 2026 in Munich, where it also presented an enhanced model of its automated PCR workflow concept CURECA. More...

The company’s standalone booth featured an interactive touchscreen “STAgora Experience Zone” and a CURECA station illustrating next-generation automated molecular workflows, drawing interest from healthcare professionals, laboratory specialists, academic researchers, and industry stakeholders.

STAgora is designed to connect PCR testing data generated around the world in real time and present aggregated statistics that clarify infectious disease trends. Demonstrations at Seegene's booth showcased dashboards comparing single‑target with syndromic PCR outputs, regional infection trends over time, pathogen‑specific positivity rates, and co‑infection patterns. Attendees also viewed how aggregated test results can be analyzed alongside regional epidemiologic indicators to support broader surveillance insights. Also showcased at the event was the enhanced CURECA model, featuring a modular, end-to-end automation architecture that integrates sample preprocessing, nucleic acid extraction, amplification, and result processing.

Visitors to Seegene's booth explored the automated PCR workflow at the CURECA station and engaged in discussions about its potential applications, while the STAgora station offered live simulations of the platform, highlighting its intuitive interface and aggregated data visualization capabilities. Together, these concepts underscore Seegene’s “From Numbers to Insights” theme, illustrating how automated testing infrastructure and real-time data analytics can be integrated to support a deeper understanding of population-level and public health trends. 

During the congress, Seegene engaged with global partners and leading laboratories to discuss adoption and validation pathways for STAgora and CURECA, and hosted dedicated sessions for healthcare and laboratory professionals. The company stated that it plans to expand collaboration with clinical, academic, and research partners to support implementation and validation of its data-driven diagnostics platform, with the goal of accelerating real-world adoption across global healthcare settings.

“STAgora is designed to connect PCR testing data generated around the world in real time and provide a clearer view of infectious disease trends based on aggregated statistics,” said Young Seag Baeg, New Business Officer at Seegene. "We are continuing to explore how real-time data analytics, combined with automated testing infrastructure, can help laboratories better understand infection patterns and expand the practical use of aggregated testing data."


New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Steam Sterilizer
Hi Vac II Line
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.